Synthetic Biology Startup Zymergen Raises $300 Million in Funding
Zymergen, a developer of biomanufacturing technologies that could reshape any number of industries, said it has raised $300 million in funding. The investment, announced on Tuesday, was led by Baillie Gifford & Co., the U.K.-based funds giant, with participation from Baron Capital Inc. and a sovereign wealth fund that declined to be identified, said Josh … Read more